In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides
about
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.In vitro synergistic activities of cefazolin and nisin A against mastitis pathogens.In vitro activity of linezolid alone and combined with other antibiotics against clinical enterococcal isolates.Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus.
P2860
In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
In vitro and in vivo activitie ...... usceptibility to glycopeptides
@ast
In vitro and in vivo activitie ...... usceptibility to glycopeptides
@en
type
label
In vitro and in vivo activitie ...... usceptibility to glycopeptides
@ast
In vitro and in vivo activitie ...... usceptibility to glycopeptides
@en
prefLabel
In vitro and in vivo activitie ...... usceptibility to glycopeptides
@ast
In vitro and in vivo activitie ...... usceptibility to glycopeptides
@en
P2093
P2860
P1476
In vitro and in vivo activitie ...... usceptibility to glycopeptides
@en
P2093
P2860
P2888
P304
P356
10.1007/S10096-010-1007-Y
P577
2010-08-01T00:00:00Z